MR Imaging is recommended for (suspected) retinoblastoma to assess disease extent, estimate metastatic risk and to screen the CNS for metastasis or RB1 mutation associated with intracranial neuroectodermal tumors (trilateral retinoblastoma). This evidence concerns the gene RB1 and retinoblastoma.